• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Biogen Idec

Biogen Idec

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Biogen Idec ’s PLEGRIDY™(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple Sclerosis

    Biogen Idec ’s PLEGRIDY™(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple Sclerosis

  2. Research and Markets: Global Multiple Sclerosis Drugs Market 2014-2018 Featuring Bayer, Biogen Idec , Merck Serono, Novartis & Teva Pharmaceutical

    Research and Markets: Global Multiple Sclerosis Drugs Market 2014-2018 Featuring Bayer, Biogen Idec , Merck Serono, Novartis & Teva Pharmaceutical

  3. UPDATE: Biotech companies take the real ice bucket challenge

    UPDATE: Biotech companies take the real ice bucket challenge

  4. Research and Markets: Growth Factors (Blood and Tissue) Market 2014 - Global Strategic Business Report

    Research and Markets: Growth Factors (Blood and Tissue) Market 2014 - Global Strategic Business Report

  5. Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy

    Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy

  6. Biotech Boom, or Bubble?

    All investments involve risk, including possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested. The information provided in this posting is not a complete analysis of every material fact regarding any country, region, ...

  7. An ETF for This Lagging Sector

    Biotech companies' returns have diverged from the broader market in recent weeks amid concerns over greater regulation and price discounting.

  8. The Sector Is Fairly Valued, but These Stocks Are Not

    A handful of health-care names are selling at premiums now, but buying opportunities are surfacing, as well.

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.